North America Endoscope Reprocessing Market

North America Endoscope Reprocessing Market Size (2024 to 2029)

The size of the North American endoscope reprocessing market is expected to be valued at USD 0.64 billion in 2024 and will grow to USD 0.96 billion by 2029, witnessing a CAGR of 8.52% during the forecast period.

The growing number of endoscopic procedures for various diseases across North America is one of the key factors driving the North American endoscope reprocessing market growth.

The growing utilization of endoscopy for the screening, diagnosis, and treatment of gastrointestinal diseases plays a pivotal role in propelling regional market growth. Recent years have witnessed nearly 40 percent of the American population suffering from various gastrointestinal ailments. Endoscopy, as a procedure, enables healthcare providers to examine the internal organs of individuals visually. It involves the insertion of a long tube through the mouth, uterus, or other relevant body openings, facilitating the detection of conditions such as gastroesophageal reflux disease, ulcers, cancer, inflammation, swelling, blockages, and other relevant issues prevalent among the population. The reprocessing of endoscope devices involves multiple steps, including precleaning, rinsing, drying, cleaning, rinsing, disinfection, and storage. These essential processes ensure the safe and effective reuse of endoscope devices.

The growing geriatric population and the rising incidence of infections following endoscopic procedures across North America further fuel the growth rate of the North American endoscope reprocessing market. The aging population is more susceptible to various health issues, often requiring diagnostic procedures to detect underlying conditions. However, older individuals are also more vulnerable to infections within hospital settings due to weakened immune systems. To mitigate the risks associated with infections, hospitals are increasingly adopting endoscope reprocessing methods performed by skilled professionals. This proactive approach not only ensures patient safety but also contributes to the growth of the endoscope reprocessing market.

The growing number of advancements in reprocessing techniques contributes to regional market growth. Manufacturers and researchers are actively engaged in developing a diverse range of devices and techniques aimed at enhancing the cleaning process for endoscopic devices. This focus on innovation has led to the creation of specialized liquids and sterilization equipment that simplify and optimize the reprocessing procedure. The significant investments in research and development, the presence of key players dedicated to driving advancements and the unwavering support of healthcare organizations promote endoscopy procedures in the North American region.

The high cost associated with the reprocessing process for endoscopes and the escalating cost of endoscopic procedures primarily hamper the North American market growth. These cost-related aspects pose significant restraints on market expansion. Factors such as a shortage of skilled professionals proficient in endoscope reprocessing, limited availability of appropriate devices for cleaning, inadequate infrastructure facilities and insufficient awareness about new techniques in the field further impede the regional market growth.

This research report on the North American endoscope reprocessing market has been segmented and sub-segmented into the following categories.

North America Endoscope Reprocessing Market Analysis By Product

High-level disinfectants And Test Strips, Detergents And Wipes, Automated Endoscope Reprocessors, Endoscope Drying, Storage And Transport Systems, Endoscope Tracking Systems, And Other Products

North America Endoscope Reprocessing Market Analysis By End User 

Hospitals, Ambulatory Surgery Centres And Others

North America Endoscope Reprocessing Market Analysis By Country

The U.S., Canada and the Rest of North America

North America held the major share of the worldwide market in 2023 and the domination of the North American region is expected to continue throughout the forecast period. The growing utilization of advanced reprocessing techniques for advanced medical devices used in diagnosis and treatment favors the market growth in the North American region.

The U.S. led the endoscope reprocessing market in North America in 2023; the lead of the U.S. market is estimated to continue during the forecast period. The government of the U.S. implemented guidelines for endoscope reprocessing procedures to minimize infection rates and enhance patient safety, which supports regional market growth. The rising awareness about the importance of early diagnosis and increasing healthcare expenditure among the U.S. population further boost the growth rate of the U.S. market. The presence of highly skilled professionals in endoscope reprocessing procedures, the introduction of novel products, the establishment of additional training centers focused on effective endoscopic reprocessing processes and the rapid adoption of minimally invasive surgeries among the population drives the growth of the U.S. market.

Canada is estimated to account for a notable share of the North American market during the forecast period owing to the rising number of laboratory centers and the adoption of endoscope devices by hospitals and specialized healthcare clinics. Hospitals in Canada make substantial investments in advanced infrastructure and implement advanced technology systems to reduce work stress on healthcare professionals. Furthermore, manufacturing centers in Canada prioritize the development of automatic endoscope reprocessing devices that require minimal human intervention.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Endoscope Reprocessing Market profiled in this report are Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others.